Cell penetrating peptides: overview and applications to the delivery of oligonucleotides

[1]  H. Moulton,et al.  A fusion peptide directs enhanced systemic dystrophin exon skipping and functional restoration in dystrophin-deficient mdx mice. , 2009, Human molecular genetics.

[2]  I. Graham,et al.  Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study , 2009, The Lancet Neurology.

[3]  Jean-Luc Coll,et al.  Targeting cyclin B1 through peptide-based delivery of siRNA prevents tumour growth , 2009, Nucleic acids research.

[4]  R. Juliano,et al.  Biological barriers to therapy with antisense and siRNA oligonucleotides. , 2009, Molecular pharmaceutics.

[5]  P. Lundin,et al.  A stearylated CPP for delivery of splice correcting oligonucleotides using a non-covalent co-incubation strategy. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[6]  M. C. Cardoso,et al.  Cell Entry of Arginine-rich Peptides Is Independent of Endocytosis*S⃞ , 2009, Journal of Biological Chemistry.

[7]  F. Edenhofer.  Protein transduction revisited: novel insights into the mechanism underlying intracellular delivery of proteins. , 2008, Current pharmaceutical design.

[8]  Noriyasu Kamei,et al.  Usefulness of cell-penetrating peptides to improve intestinal insulin absorption. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[9]  B. Lebleu,et al.  Improved cell-penetrating peptide–PNA conjugates for splicing redirection in HeLa cells and exon skipping in mdx mouse muscle , 2008, Nucleic acids research.

[10]  P. Iversen,et al.  Effective rescue of dystrophin improves cardiac function in dystrophin-deficient mice by a modified morpholino oligomer , 2008, Proceedings of the National Academy of Sciences.

[11]  P. Iversen,et al.  Delivery of steric block morpholino oligomers by (R-X-R)4 peptides: structure–activity studies , 2008, Nucleic acids research.

[12]  H. Moulton,et al.  Cell-penetrating peptide-conjugated antisense oligonucleotides restore systemic muscle and cardiac dystrophin expression and function , 2008, Human molecular genetics.

[13]  P. Iversen,et al.  Sustained dystrophin expression induced by peptide-conjugated morpholino oligomers in the muscles of mdx mice. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[14]  C. Contag,et al.  Overcoming multidrug resistance of small-molecule therapeutics through conjugation with releasable octaarginine transporters , 2008, Proceedings of the National Academy of Sciences.

[15]  Ralph Weissleder,et al.  Multifunctional magnetic nanoparticles for targeted imaging and therapy. , 2008, Advanced drug delivery reviews.

[16]  B. Cornelissen,et al.  Cell penetrating peptides for in vivo molecular imaging applications. , 2008, Current pharmaceutical design.

[17]  T. Restle,et al.  Recent Developments in Peptide-Based Nucleic Acid Delivery , 2008, International journal of molecular sciences.

[18]  M. Morris,et al.  Cell‐penetrating peptides: from molecular mechanisms to therapeutics , 2008, Biology of the cell.

[19]  P. Iversen,et al.  Arginine‐rich cell penetrating peptides: Design, structure–activity, and applications to alter pre‐mRNA splicing by steric‐block oligonucleotides , 2008, Journal of peptide science : an official publication of the European Peptide Society.

[20]  Vladimir P Torchilin,et al.  Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers. , 2008, Advanced drug delivery reviews.

[21]  P. Wender,et al.  The design of guanidinium-rich transporters and their internalization mechanisms. , 2008, Advanced drug delivery reviews.

[22]  A. Prochiantz,et al.  Homeoproteins as natural Penetratin cargoes with signaling properties. , 2008, Advanced drug delivery reviews.

[23]  S. Ohta,et al.  PTD-mediated delivery of anti-cell death proteins/peptides and therapeutic enzymes. , 2008, Advanced drug delivery reviews.

[24]  Johan T den Dunnen,et al.  Local dystrophin restoration with antisense oligonucleotide PRO051. , 2007, The New England journal of medicine.

[25]  D. A. Stein,et al.  Cell penetrating peptide conjugates of steric block oligonucleotides☆ , 2007, Advanced Drug Delivery Reviews.

[26]  G. van Ommen,et al.  Antisense-mediated exon skipping: a versatile tool with therapeutic and research applications. , 2007, RNA.

[27]  P. Iversen,et al.  Morpholino oligomer-mediated exon skipping averts the onset of dystrophic pathology in the mdx mouse. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[28]  L. Chen,et al.  Cell-penetrating peptides in drug development: enabling intracellular targets. , 2007, Biochemical Society transactions.

[29]  Rainer Fischer,et al.  A Comprehensive Model for the Cellular Uptake of Cationic Cell‐penetrating Peptides , 2007, Traffic.

[30]  B. Lebleu,et al.  Efficient splicing correction by PNA conjugation to an R6-Penetratin delivery peptide , 2007, Nucleic acids research.

[31]  A. Prochiantz,et al.  The topological role of homeoproteins in the developing central nervous system , 2007, Trends in Neurosciences.

[32]  You Han Bae,et al.  TAT peptide-based micelle system for potential active targeting of anti-cancer agents to acidic solid tumors. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[33]  D. A. Stein,et al.  Antiviral Effects of Antisense Morpholino Oligomers in Murine Coronavirus Infection Models , 2007, Journal of Virology.

[34]  M. Rezaee,et al.  Impaired perfusion after myocardial infarction is due to reperfusion-induced deltaPKC-mediated myocardial damage. , 2007, Cardiovascular research.

[35]  S. Donnini,et al.  TAT‐BH4 counteracts Aβ toxicity on capillary endothelium , 2007 .

[36]  P. Iversen,et al.  Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[37]  S. Dowdy,et al.  Influence of protein transduction domains on intracellular delivery of macromolecules , 2006, Expert opinion on drug delivery.

[38]  J. Rothbard,et al.  Molecular Transporters: Synthesis of Oligoguanidinium Transporters and Their Application to Drug Delivery and Real‐Time Imaging , 2006, Chembiochem : a European journal of chemical biology.

[39]  E. Hovig,et al.  Photochemically induced gene silencing using PNA-peptide conjugates. , 2006, Oligonucleotides.

[40]  Alain Thierry,et al.  Endosome trapping limits the efficiency of splicing correction by PNA-oligolysine conjugates. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[41]  P. Nielsen,et al.  Photochemically enhanced cellular delivery of cell penetrating peptide‐PNA conjugates , 2006, FEBS letters.

[42]  S. Wilton,et al.  Dystrophin expression in the mdx mouse after localised and systemic administration of a morpholino antisense oligonucleotide , 2006, The journal of gene medicine.

[43]  A. Rabinowitz,et al.  Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology , 2006, Nature Medicine.

[44]  B. Lebleu,et al.  Cell-penetrating peptide conjugates of peptide nucleic acids (PNA) as inhibitors of HIV-1 Tat-dependent trans-activation in cells , 2005, Nucleic acids research.

[45]  Jesus M de la Fuente,et al.  Tat peptide as an efficient molecule to translocate gold nanoparticles into the cell nucleus. , 2005, Bioconjugate chemistry.

[46]  P. Nielsen,et al.  Calcium ions effectively enhance the effect of antisense peptide nucleic acids conjugated to cationic tat and oligoarginine peptides. , 2005, Chemistry & biology.

[47]  B. Lebleu,et al.  Cellular Uptake of Unconjugated TAT Peptide Involves Clathrin-dependent Endocytosis and Heparan Sulfate Receptors* , 2005, Journal of Biological Chemistry.

[48]  Steven F Dowdy,et al.  Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer. , 2005, Advanced drug delivery reviews.

[49]  Steven F Dowdy,et al.  Cationic TAT peptide transduction domain enters cells by macropinocytosis. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[50]  A. Rabinowitz,et al.  Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[51]  Roger Y Tsien,et al.  Tumor imaging by means of proteolytic activation of cell-penetrating peptides. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[52]  W. Jiskoot,et al.  OVCAR-3 cells internalize TAT-peptide modified liposomes by endocytosis. , 2004, Biochimica et biophysica acta.

[53]  Joseph Rosenecker,et al.  Application of Novel Solid Lipid Nanoparticle (SLN)-Gene Vector Formulations Based on a Dimeric HIV-1 TAT-Peptide in Vitro and in Vivo , 2004, Pharmaceutical Research.

[54]  G. Steinberg,et al.  Protein Kinase C δ Mediates Cerebral Reperfusion Injury In Vivo , 2004, The Journal of Neuroscience.

[55]  M. Giacca,et al.  Cell membrane lipid rafts mediate caveolar endocytosis of HIV-1 Tat fusion proteins. , 2004, The Journal of biological chemistry.

[56]  F. Rayne,et al.  HIV-1 Tat enters T cells using coated pits before translocating from acidified endosomes and eliciting biological responses. , 2004, Molecular biology of the cell.

[57]  Steven F Dowdy,et al.  Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis , 2004, Nature Medicine.

[58]  S. Gellman,et al.  Cytoplasmic and Nuclear Delivery of a TAT-derived Peptide and a β-Peptide after Endocytic Uptake into HeLa Cells* , 2003, Journal of Biological Chemistry.

[59]  Kurt Ballmer-Hofer,et al.  Antennapedia and HIV Transactivator of Transcription (TAT) “Protein Transduction Domains” Promote Endocytosis of High Molecular Weight Cargo upon Binding to Cell Surface Glycosaminoglycans* , 2003, Journal of Biological Chemistry.

[60]  Michael G. Yang,et al.  Arginine-based molecular transporters: the synthesis and chemical evaluation of releasable taxol-transporter conjugates. , 2003, Organic letters.

[61]  V. Torchilin,et al.  TAT-liposomes: a novel intracellular drug carrier. , 2003, Current protein & peptide science.

[62]  J. Mottram,et al.  Novel peptide inhibitors of Leishmania gp63 based on the cleavage site of MARCKS (myristoylated alanine-rich C kinase substrate)-related protein. , 2002, The Biochemical journal.

[63]  Y. Tseng,et al.  Translocation of liposomes into cancer cells by cell-penetrating peptides penetratin and tat: a kinetic and efficacy study. , 2002, Molecular pharmacology.

[64]  B. L. Wylie,et al.  Arginine-rich molecular transporters for drug delivery: role of backbone spacing in cellular uptake. , 2002, Journal of medicinal chemistry.

[65]  M. Johansson,et al.  Positively charged DNA-binding proteins cause apparent cell membrane translocation. , 2002, Biochemical and biophysical research communications.

[66]  T. Bártfai,et al.  Cargo delivery kinetics of cell-penetrating peptides. , 2001, Biochimica et biophysica acta.

[67]  M. Manoharan,et al.  Nuclear antisense effects of neutral, anionic and cationic oligonucleotide analogs. , 2001, Nucleic acids research.

[68]  H. Inokuchi,et al.  Protein Transduction Domain of HIV-1 Tat Protein Promotes Efficient Delivery of DNA into Mammalian Cells* , 2001, The Journal of Biological Chemistry.

[69]  V. Torchilin,et al.  TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[70]  E. Snyder,et al.  Protein/peptide transduction domains: potential to deliver large DNA molecules into cells. , 2001, Current opinion in molecular therapeutics.

[71]  D. Mukhopadhyay,et al.  The 104-123 amino acid sequence of the beta-domain of von Hippel-Lindau gene product is sufficient to inhibit renal tumor growth and invasion. , 2001, Cancer research.

[72]  G. Drin,et al.  Physico-chemical requirements for cellular uptake of pAntp peptide. Role of lipid-binding affinity. , 2001, European journal of biochemistry.

[73]  R. Brasseur,et al.  Translocation of the pAntp peptide and its amphipathic analogue AP-2AL. , 2001, Biochemistry.

[74]  C. Mann,et al.  Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[75]  J. Rothbard,et al.  Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation , 2000, Nature Medicine.

[76]  J. Rothbard,et al.  Polyarginine enters cells more efficiently than other polycationic homopolymers. , 2000, The journal of peptide research : official journal of the American Peptide Society.

[77]  D. Piwnica-Worms,et al.  Novel Tat-peptide chelates for direct transduction of technetium-99m and rhenium into human cells for imaging and radiotherapy. , 2000, Bioconjugate chemistry.

[78]  R Weissleder,et al.  Macrocyclic chelators with paramagnetic cations are internalized into mammalian cells via a HIV-tat derived membrane translocation peptide. , 2000, Bioconjugate chemistry.

[79]  S. Schwarze,et al.  In vivo protein transduction: delivery of a biologically active protein into the mouse. , 1999, Science.

[80]  R Weissleder,et al.  High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. , 1999, Bioconjugate chemistry.

[81]  B. Wiesner,et al.  Cellular uptake of an alpha-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior non-endocytically. , 1998, Biochimica et biophysica acta.

[82]  T. Hökfelt,et al.  Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo , 1998, Nature Biotechnology.

[83]  M. Manoharan,et al.  Modification of splicing in the dystrophin gene in cultured Mdx muscle cells by antisense oligoribonucleotides. , 1998, Human molecular genetics.

[84]  R. Kole,et al.  Up-regulation of luciferase gene expression with antisense oligonucleotides: implications and applications in functional assay development. , 1998, Biochemistry.

[85]  C. Granier,et al.  Structure-activity relationship study of the plasma membrane translocating potential of a short peptide from HIV-1 Tat protein , 1997, Letters in Peptide Science.

[86]  L. Chaloin,et al.  A new peptide vector for efficient delivery of oligonucleotides into mammalian cells. , 1997, Nucleic acids research.

[87]  Priscille Brodin,et al.  A Truncated HIV-1 Tat Protein Basic Domain Rapidly Translocates through the Plasma Membrane and Accumulates in the Cell Nucleus* , 1997, The Journal of Biological Chemistry.

[88]  M. Hasegawa,et al.  Identification of a binding region onEscherichia coli heat-stable enterotoxin to intestinal guanylyl cyclase C , 1997, Letters in Peptide Science.

[89]  A. Prochiantz,et al.  The third helix of the Antennapedia homeodomain translocates through biological membranes. , 1994, The Journal of biological chemistry.

[90]  J Barsoum,et al.  Tat-mediated delivery of heterologous proteins into cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[91]  A. Prochiantz,et al.  alpha-2,8-Polysialic acid is the neuronal surface receptor of antennapedia homeobox peptide. , 1991, The New biologist.

[92]  Carl O. Pabo,et al.  Cellular uptake of the tat protein from human immunodeficiency virus , 1988, Cell.

[93]  Vladimir P Torchilin,et al.  Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery. , 2008, Biopolymers.

[94]  Hans P Merkle,et al.  On the biomedical promise of cell penetrating peptides: limits versus prospects. , 2008, Journal of pharmaceutical sciences.

[95]  S. Donnini,et al.  TAT-BH4 counteracts Abeta toxicity on capillary endothelium. , 2007, FEBS letters.

[96]  Y. Tsujimoto,et al.  BH4 peptide derivative from Bcl-xL attenuates ischemia/reperfusion injury thorough anti-apoptotic mechanism in rat hearts. , 2005, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[97]  G. Steinberg,et al.  Protein kinase C delta mediates cerebral reperfusion injury in vivo. , 2004, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[98]  E. Vivés,et al.  Structure–activity relationship study of the plasma membrane translocating potential of a short peptide from HIV-1 Tat protein , 2004, Letters in Peptide Science.

[99]  E. Vivés,et al.  Cell-penetrating Peptides A REEVALUATION OF THE MECHANISM OF CELLULAR UPTAKE* , 2002 .

[100]  M. Pooga,et al.  Cell penetration by transportan. , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.